TrialCancer science2020

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100.

Shin Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.